Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 in Stage IV NSCLC With Driver Molecular Alterations
NCT01922583Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Luminespib in non-small cell lung cancer (NSCLC), sponsored by National Taiwan University Hospital. Started Jan 2014; status: completed.
02
Drugs
Luminespib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01922583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922583.